CANNABIDIOL MARKET ANALYSIS

Cannabidiol Market, By Source Type (Hemp and Marijuana), By Product (Oil, Tinctures, Suppository, Transdermal patches, Vape Oil Isolates, Creams and Roll-on, Capsules, Tablet, Others), By Application (Medical, Personal Use, Pharmaceuticals, Wellness , Food & Beverages, Personal Care & Cosmetics, Nutraceuticals, Others), By Distribution Channel (Hospital Pharmacies, Online Stores, Retail Stores), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

In January 2023, Medical Marijuana, Inc.'s subsidiary HempMedsBrasil introduced two new full-spectrum cannabidiol products in Brazil, available in concentrations ranging from 3,000-6,000 mg and sizes of 30 mL and 60 mL.
In October 2022, Medical Marijuana, Inc. announced a collaboration between its subsidiary HempMeds Mexico, the Autonomous University of Barcelona in Spain, and the Meritorious Autonomous University of Puebla in Mexico to study the therapeutic benefits of cannabidiol in treating Parkinson’s disease.
Also in October 2022, High Tide, Inc. launched multi-cannabinoid products through its subsidiary NuLeaf Naturals in Ontario, Canada. Offerings include Full Spectrum Hemp Multi cannabinoid oil and plant-based softgels containing delta-9 tetrahydrocannabinol, cannabichromene, Cannabidiol, cannabigerol, and cannabinol.
In September 2022, Kannaway, another subsidiary of Medical Marijuana, Inc., expanded its partnership with Complete Hemp Technologies (CHT) in Europe. The agreement enhanced CHT’s services to Kannaway by adding warehousing and daily operations to support the company’s regional operations.
In January 2022, Elixinol launched two new cannabidiol products focused on promoting sleep: Sleep Rapid Rest Liposome and Sleep Gummies. The Sleep Rapid Rest Liposome features a blend of CBN, cannabidiol, chamomile, and lemon balm, while the Sleep Gummies contain 2mg of CBN and 15mg of cannabidiol.